Compare BFS & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFS | INMD |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | United States | Israel |
| Employees | 98 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 809.1M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | BFS | INMD |
|---|---|---|
| Price | $36.78 | $13.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 5 |
| Target Price | ★ $44.00 | $17.33 |
| AVG Volume (30 Days) | 53.1K | ★ 842.3K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.92% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.30 | $1.74 |
| Revenue Next Year | $5.67 | $3.26 |
| P/E Ratio | $30.48 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.16 | $12.72 |
| 52 Week High | $37.42 | $16.74 |
| Indicator | BFS | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 71.48 | 42.58 |
| Support Level | $30.93 | $13.27 |
| Resistance Level | N/A | $13.87 |
| Average True Range (ATR) | 0.71 | 0.26 |
| MACD | 0.25 | -0.03 |
| Stochastic Oscillator | 87.08 | 27.75 |
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.